| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 1.878 | 2.908 | 3.401 | 4.326 | 8.659 | 24.967 | 26.795 |
| Total Income - EUR | - | - | - | 1.878 | 2.908 | 3.401 | 4.326 | 8.659 | 24.967 | 26.795 |
| Total Expenses - EUR | - | - | - | 1.781 | 2.491 | 948 | 1.966 | 15.382 | 25.322 | 24.777 |
| Gross Profit/Loss - EUR | - | - | - | 97 | 417 | 2.453 | 2.360 | -6.724 | -355 | 2.017 |
| Net Profit/Loss - EUR | - | - | - | 41 | 329 | 2.351 | 2.231 | -6.810 | -605 | 1.603 |
| Employees | - | - | - | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Carmazol Office Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 325 | 203 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 221 | 763 | 3.546 | 5.694 | 1.081 | 1.202 | 101 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 124 | 0 | 0 | 0 | 0 |
| Cash | - | - | - | 221 | 763 | 3.421 | 5.694 | 1.081 | 1.202 | 101 |
| Shareholders Funds | - | - | - | 84 | 411 | 2.568 | 4.741 | -2.054 | -2.653 | -1.035 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 462 | 555 | 978 | 952 | 3.136 | 3.855 | 1.135 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6920 - 6920" | |||||||||
| CAEN Financial Year |
6920
|
|||||||||
Comments - Carmazol Office Srl